Life Sciences Insights

Training AI to Accurately Identify Biomarkers in Tumor Biospecimens

AI biomarker identification relies on whole slide imaging and diverse tumor biospecimens to train digital pathology models that support precision...

Accelerating the Path to IND: Integrated ADC and Bispecific Workflows

The transition from lead candidate to Investigational New Drug (IND) filing is often delayed by the logistical complexity of managing...

Five Key Areas of a Buyer’s Decision Qualification

There are five key areas that sellers must understand from prospective customers that will be used to make a purchasing...

Enhance Your Recruitment & Retention Strategy For Rare Kidney Disease Trials

Breakthroughs in genetic understanding alongside the growing shift toward accommodating orphan drugs have led to an upswing in clinical trials...

Maximizing Clinical Trial Access With AI

AI clinical trial matching uses large language models to pair patients with studies in minutes, easing the bottleneck that stalls...

September Update: Antibody Industry Trends (Q3 2026 Insights, Trends & Analysis)

Biointron’s Q3 2026 Antibody Industry Trends report aims to explore the events and trends of the biopharmaceutical industry in July,...

Meet the Winners and Finalists of the 23rd Annual Pantheon Awards

2026 Pantheon Awards winners and finalists: meet the seven honorees and five Emerging Innovator finalists CLS will celebrate on November...

How Australia’s Leading CRO Is Driving Biotech’s Acceleration From First-In-Human To Global Markets

CEO of Avance Clinical, Mark Harvill found his way into the clinical research space by chance, or perhaps more accurately,...

From Lab to Patient: Key Takeaways from the 2026 Cell and Gene Therapy Symposium

Table of Contents Bringing Precision Medicine to the Heart Rethinking the Path for Rare Disease Therapies Advancing Gene Editing from...